as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
4.26%
Downside
4.96%
Upside
52 Week's Low
52 Week's High
60.95%
Downside
339.01%
Upside
Check Citius Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$120.3M
EPS (TTM)
-0.33
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-107.54%
Compare market cap, revenue, PE, and other key metrics of Citius Oncology Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $120.3M | NA | NA | 0.00% | |
| BUY | $19.3B | NA | 17.02 | 40.65% | |
| BUY | $41.9B | NA | 21.88 | 13.81% | |
| BUY | $15.4B | 58.16% | 36.95 | 15.95% | |
| BUY | $52.7B | -28.96% | 20.13 | 28.21% |
The Citius Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Citius Oncology Inc investment value today
Current value as on today
₹1,16,171
Returns
₹16,171
(+16.17%)
Returns from Citius Oncology Inc Stock
₹11,024 (+11.02%)
Dollar Returns*
₹5,147 (+5.15%)
Search interest for Citius Oncology Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 23.1% return, outperforming this stock by 9.7%
Price Dip
![]()
In the last 7 days, CTOR stock has moved down by -17.7%
| Organisation | Citius Oncology Inc |
| Headquarters | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
| CEO | Mr. Leonard L. Mazur |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Myron Z. Holubiak | Secretary & Executive Vice Chairman |
Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
Mr. Jaime Bartushak | CFO & Chief Business Officer |
Mr. Leonard L. Mazur | CEO, President & Executive Chairman |
Citius Oncology Inc share price today is $1.41 as on at the close of the market. Citius Oncology Inc share today touched a day high of $1.48 and a low of $1.35.
Citius Oncology Inc share touched a 52 week high of $6.19 on and a 52 week low of $0.55 on . Citius Oncology Inc stock price today i.e. is closed at $1.41,which is 77.22% down from its 52 week high and 156.08% up from its 52 week low.
Citius Oncology Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Citius Oncology Inc (CTOR) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Citius Oncology Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Citius Oncology Inc share’s latest price of $1.41 as on November 8, 2025 at 2:29 am IST, you will get 7.0922 shares of Citius Oncology Inc. Learn more about
fractional shares .